AI-Generated Content — This profile was created using AI. While we strive for accuracy, details may not be perfectly precise.
Peter Attia
United States
Net Worth
$15M+
Source of Wealth
Author / Outlive / Early Medical
Global Rank
#133 of 157
About Peter Attia
Peter Attia is a physician, author, and longevity medicine pioneer whose book Outlive: The Science and Art of Longevity became one of the most important health books of the 2020s. A former McKinsey consultant and Johns Hopkins-trained surgeon who retrained himself in the emerging science of longevity, Attia has become the leading voice arguing that modern medicine's approach to chronic disease is fundamentally broken — and that we need to shift from 'Medicine 2.0' (treating disease after it appears) to 'Medicine 3.0' (preventing disease decades before symptoms emerge).
Attia's unconventional path began in Canada, where he grew up in Toronto as the son of Egyptian immigrants. After earning his medical degree from Stanford University School of Medicine, he trained in general surgery at Johns Hopkins Hospital and planned a career in surgical oncology. But watching patients die of preventable diseases led him to question whether treating late-stage illness was the best use of his talents.
He left surgery, spent two years at the National Cancer Institute studying the relationship between metabolism and cancer, then founded Attia Medical PC (later Early Medical), a private medical practice focused on applying the principles of longevity medicine to individual patients. His practice focuses on the 'four horsemen' of chronic disease: heart disease, cancer, neurodegenerative disease, and metabolic dysfunction.
His podcast, The Drive, features deep-dive conversations with leading scientists, physicians, and researchers. Published in 2023, Outlive spent months atop the New York Times bestseller list and gave millions of readers a framework for thinking about healthspan — not just lifespan.
Key Achievements
Outlive: #1 New York Times Bestseller
Published Outlive: The Science and Art of Longevity in 2023, a groundbreaking book that spent months on the New York Times bestseller list and provided the most comprehensive framework for longevity medicine available to the public.
Pioneered Medicine 3.0
Articulated and popularized the concept of 'Medicine 3.0' — a proactive approach to healthcare that focuses on preventing the four horsemen of chronic disease decades before symptoms appear, rather than treating them after the fact.
Stanford MD and Johns Hopkins Surgical Training
Earned his medical degree from Stanford and completed surgical residency at Johns Hopkins Hospital — two of the most prestigious medical institutions in the world — before pivoting to longevity medicine.
Built The Drive Podcast
Created one of the most respected health and science podcasts, featuring multi-hour deep dives with world-class researchers on topics from cardiovascular disease to Alzheimer's prevention to exercise physiology.
Former McKinsey Consultant Turned Physician
Before medical school, worked as a consultant at McKinsey & Company, developing the analytical rigor and systems thinking he later applied to rethinking how medicine approaches chronic disease.
Notable Quotes
“The objective of Medicine 3.0 is not to patch people up and get them out the door, but to prevent the diseases that will kill them.”
— Peter Attia
“Exercise is by far the most potent longevity drug. No other intervention comes close.”
— Peter Attia
“If you have to choose one form of exercise, it should be strength training. Muscle is the organ of longevity.”
— Peter Attia
Key Decisions
Left McKinsey & Company to attend Stanford Medical School, trading a lucrative consulting career for the long road of medical training.
Began surgical residency at Johns Hopkins Hospital, training under some of the best surgeons in the world in one of medicine's most demanding programs.
Left surgical oncology to study metabolism and cancer at the National Cancer Institute, choosing prevention research over a traditional surgical career.
Founded his private longevity medicine practice, applying cutting-edge research to helping individual patients prevent chronic disease decades before it typically manifests.
Launched The Drive podcast, creating a platform for the deepest, most rigorous health conversations available to the public.
Published Outlive: The Science and Art of Longevity, giving millions of readers the framework for thinking about healthspan and longevity that had previously been available only to his private patients.
Early Life
Born March 19, 1973, in Toronto, Canada, Peter Attia is the son of Egyptian immigrants. He grew up in Toronto, excelling in academics and boxing (he was a Canadian junior national champion). He studied mechanical engineering and applied mathematics at Queen's University in Ontario before attending Stanford Medical School, where he graduated among the top of his class.
Life Lessons & Insights
Exercise Is the Ultimate Longevity Drug
No pharmaceutical, supplement, or biohack comes close to the benefits of regular exercise. Attia's framework emphasizes four pillars: stability, strength, aerobic efficiency (zone 2), and peak aerobic output (VO2 max).
Think in Decades, Not Symptoms
The four horsemen — heart disease, cancer, neurodegeneration, and metabolic dysfunction — develop over decades. By the time you have symptoms, you've already lost years. Prevention must start 20-30 years before typical diagnosis.
Healthspan Matters More Than Lifespan
Living to 100 means nothing if the last 20 years are spent in decline. Attia's focus is on the Marginal Decade — making the last decade of your life as vibrant as possible by training for it now.
Emotional Health Is the Fifth Pillar
Attia has been open about his own struggles with emotional health and anger. He argues that longevity means nothing without the emotional capacity to enjoy it — a lesson he learned through intensive therapy.
Deep Dives
Go deeper into what makes Peter Attia exceptional.
Explore More
See how Glen Bradford applies these principles to his own investing. Long Fannie Mae & Freddie Mac junior preferred — and not going anywhere.